van Benthem, P., Spijkerman, R., Blanken, P., Kleinjan, M., Vermeiren, R. R., & Hendriks, V. M. (2020). A dual perspective on first-session therapeutic alliance: strong predictor of youth mental health and addiction treatment outcome. European child & adolescent psychiatry, 29, 1593-1601. doi: 10.1007/s00787-020-01503-w.
Bhaskar, S., Bradley, S., Israeli-Korn, S., Menon, B., Chattu, V. K., Thomas, P., ..., Özgen, M. H.,... & Mederer Hengstl, S. (2020). Chronic neurology in COVID-19 era: clinical considerations and recommendations from the REPROGRAM consortium. Frontiers in neurology, 11, 664. doi: 10.3389/fneur.2020.00664.
Blanken, P., Nuijten, M., van den Brink, W., & Hendriks, V. M. (2020). Clinical effects beyond cocaine use of sustained‐release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double‐blind, placebo‐controlled randomized trial. Addiction, 115(5), 917-923. doi: 10.1111/add.14874.
Van Dooren, M. M., Visch, V., Spijkerman, R., Goossens, R. H., & Hendriks, V. M. (2020). Mental health therapy protocols and ehealth design: focus group study. JMIR Formative Research, 4(5), e15568. doi: 10.1159/000508385.
Özgen, H., Spijkerman, R., Noack, M., Holtmann, M., Schellekens, A. S., Van De Glind, G., ... & Hendriks, V. (2020). International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent attention-deficit/hyperactivity disorder and substance use disorder. European addiction research, 26(4-5), 223-232. doi: 10.1159/000508385.
Randesi, M., Levran, O., den Brink, W. V., Blanken, P., van Ree, J. M., Ott, J., & Kreek, M. J. (2020). Further evidence for the association of GAL, GALR1 and NPY1R variants with opioid dependence. Pharmacogenomics, 21(13), 903-917. doi: 10.2217/pgs-2020-0045.